Transforming growth factor-β plasma dynamics and post-irradiation lung injury in lung cancer patients

This publication has 40 references indexed in Scilit:

• Risk of long-term complications after TFG-β1–guided very-high-dose thoracic radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Using Plasma Transforming Growth Factor Beta-1 During Radiotherapy to Select Patients for Dose Escalation
  Journal of Clinical Oncology, 2001
• Plasma transforming growth factor β1 as a predictor of radiation pneumonitis
  International Journal of Radiation Oncology*Biology*Physics, 1998
• The relevance of transforming growth factor β1 in pulmonary injury after radiation therapy
  Lung Cancer, 1998
• Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβ
  The British Journal of Radiology, 1995
• Changes in plasma TGFβ levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis
  International Journal of Radiation Oncology*Biology*Physics, 1994
• An Assay for Transforming Growth Factor-β Using Cells Transfected with a Plasminogen Activator Inhibitor-1 Promoter-Luciferase Construct
  Analytical Biochemistry, 1994
• Transforming growth factor-beta activation in irradiated murine mammary gland.
  Journal of Clinical Investigation, 1994
• Transforming Growth Factor-β1 Expression in Irradiated Liver
  Radiation Research, 1990